Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2025-12-24 @ 1:29 PM
NCT ID:
NCT05956795
Eligibility Criteria:
Inclusion Criteria:
* All cSCC must be on the head or neck
* All cSCC must be primary tumors.
* BWH stage T2a tumors in patients who are on chronic immunosuppression (organ transplant, hematologic malignancy, autoimmune disease)
* All BWH T2b or T3 tumors with a negative CT of the nodal basin AND a negative SLNB
Exclusion Criteria:
* Recurrent tumors
* Patients who are BWH T2b/T3 who have a positive CT of the nodal basin or positive lymph node biopsy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05956795
Study Brief:
Protocol Section:
NCT05956795